This journal is on the Chinese Academy of Sciences early-warning list (for example for unusual citation patterns or very high publication volume). Many universities do not count papers in it; ask your supervisor before you submit.
Metrics
- Impact factor
- 3.5+0.1 Clarivate JCR
- WoS quartile
- Q2 Clarivate JCR, best category
- SJR
- 0.955Q1 SCImago
- h-index
- 111
- CAS tier
- Tier 3 Chinese Academy of Sciences
- Citations per paper
- 3.61 last 2 years
- Articles per year
- 1,440
- Self-citation
- 17.3%
- Fee (APC), est.
- $3,426 estimated, check the journal
About this journal
- ISSN
- 2076-393X (print)
- Publisher
- MDPI (Basel, Switzerland) · MDPI
- Country
- Switzerland · Western Europe
- Indexed in
- SCIE
- Access
- Gold OA · 100% gold OA
- Founded
- 2013
- Original research
- 84.6%
- Subject areas
- Immunology and Microbiology, Medicine, Pharmacology, Toxicology and Pharmaceutics
- Categories
- Pharmacology, Toxicology and Pharmaceutics
- Common topics
- Medicine, Biology, Immunology, Virology, Pathology
Similar journals
- Q2WoS
Journal of Immunology
Impact factor 4h-index 345SJR 1.44 - Q2WoS
Journal of Bacteriology
Impact factor 3.8h-index 222SJR 1.40 - Q2WoS
Infection and Immunity
Impact factor 3.4h-index 204SJR 1.17 - Q2WoS
Aids
Impact factor 2.9h-index 203SJR 1.14 - Q2WoS
Applied Microbiology and Biotechnology
Impact factor 4.7h-index 198SJR 1.01 - Q2WoS
European Journal of Immunology
Impact factor 4.1h-index 187SJR 1.67
Figures as of the last import; ranks are a guide, not a verdict. Back to all journals